A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.

Edits on 7 Dec, 2023

"update inverses"

Golden AI

edited on 7 Dec, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11833130 Treatment of circadian rhythm disorders

Edits on 18 Oct, 2023

"update inverses"

Golden AI

edited on 18 Oct, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11786502 Method of treatment

Edits on 1 Oct, 2023

"Add patent inventor(s)"

Golden AI

edited on 1 Oct, 2023

Edits made to:

Infobox (+3 properties)

Infobox

Patent Inventor Names

Deepak Phadke0

Natalie M Platt0

Ravi K Pandrapragada0

Edits on 30 Apr, 2023

"update inverses"

Golden AI

edited on 30 Apr, 2023

Edits made to:

Infobox (+1 properties)

Infobox

Patent Citations Received

‌

US Patent 11633377 Treatment of circadian rhythm disorders

Edits on 22 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 22 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 11285129 Treatment of circadian rhythm disorders

Edits on 5 Apr, 2023

"update citations for inverse infoboxes"

Golden AI

edited on 5 Apr, 2023

Infobox

Patent Citations Received

‌

US Patent 10610510 Treatment of circadian rhythm disorders

Edits on 28 Sep, 2022

"update citations for inverse infoboxes"

Golden AI

edited on 28 Sep, 2022

Infobox

Patent Citations Received

‌

US Patent 10610510 Treatment of circadian rhythm disorders

"Entity importer update"

Golden AI

edited on 28 Sep, 2022

Infobox

Is a

Patent

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100719770

Date of Patent

September 11, 2018

Patent Application Number

151177340

Date Filed

February 12, 2015

Patent Citations Received

‌

US Patent 10610510 Treatment of circadian rhythm disorders

‌

US Patent 10945988 Treatment of circadian rhythm disorders

‌

US Patent 11285129 Treatment of circadian rhythm disorders

Patent Primary Examiner

‌

Timothy R Rozof

Edits on 30 Mar, 2022

"update inverses"

Golden AI

edited on 30 Mar, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 11285129 Treatment of circadian rhythm disorders

Edits on 10 Feb, 2022

"update inverses"

Golden AI

edited on 10 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 10945988 Treatment of circadian rhythm disorders

Edits on 2 Feb, 2022

"update inverses"

Golden AI

edited on 2 Feb, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Patent citations received

‌

US Patent 10610510 Treatment of circadian rhythm disorders

Edits on 22 Jan, 2022

"Created via: Entity Importer"

Golden AI

created this topic on 22 Jan, 2022

Edits made to:

Infobox (+7 properties)

‌

US Patent 10071977 Highly purifid pharmaceutical grade tasimelteon

Infobox

Is a

Patent

Patent jurisdiction

United States Patent and Trademark Office

Patent number

10071977

Date of patent

September 11, 2018

Patent application number

15117734

Date Filed

February 12, 2015

Patent primary examiner

‌

Timothy R Rozof

Find more entities like US Patent 10071977 Highly purifid pharmaceutical grade tasimelteon

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API